Melinta Therapeutics, Inc. (NASDAQ:MLNT)

7.45
Delayed Data
As of 4:00pm ET
 +0.35 / +4.93%
Today’s Change
6.50
Today|||52-Week Range
24.25
-52.85%
Year-to-Date
No recent news for Melinta Therapeutics, Inc..

Today’s Trading

Previous close7.10
Today’s open7.05
Day’s range7.05 - 7.60
Volume144,245
Average volume (3 months)164,600
Market cap$421.3M
Data as of 4:00pm ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)-11.96%
Earnings growth (this year)+58.89%
Earnings growth (next 5 years)--
Revenue growth (last year)-34.03%
P/E ratioNM
Price/Sales7.82
Price/Book0.77

Competitors

 Today’s
change
Today’s
% change
ACRXAcelRx Pharmaceutica...+0.02+1.04%
CDMOAvid Bioservices Inc+0.15+4.79%
RDHLRedhill Biopharma Lt...+0.07+1.42%
TRVNTrevena Inc0.000.00%
Data as of 4:00pm ET, 04/19/2018

Financials

Next reporting dateApril 27, 2018
EPS forecast (this quarter)-$4.20
Annual revenue (last year)$18.0M
Annual profit (last year)-$118.0M
Net profit margin-654.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Daniel Mark Wechsler
CFO, Secretary &
Principal Accounting Officer
Paul Estrem
Corporate headquarters
New Haven, Connecticut

Forecasts